SAMA has two large clinics including a medical unit providing one-day hospitalization, a kinetotherapy center, two occupational medicine centers, six laboratories and several blood testing units.
SAMA shareholders include Alida Olivia Gogescu (65%) and Eduard Sorin Stanov (35%) and Ultratest’s shareholding structure includes Danut Gogescu (45%) and Daniela Liliana Stanov (55%).
According to MedLife representatives, SAMA group is the leading medical laboratory services provider in the region of Oltenia and one of the largest operators in the outpatient services sector in the region. In 2014, Sama’s turnover exceeded EUR800,000.
“2015 is very important for MedLife’s development and the plan is to invest over EUR10 million in opening new units and/or making new acquisitions regionally. Oltenia is a new market for MedLife and carrying out operations in this region, through growth or acquisition, represents another step towards fulfilling our business target to be present in all the country’s historical regions,” said Mihai Marcu, company board chairman Mihai Marcu said in a press release.
In 2010, MedLife bought 80% in the group Policlinica de Diagnostic Rapid in Brasov. The acquisition topped EUR3 million and is the largest operation for the purchase of a local medical services provider in Romania by another local medical services operator. The transaction was followed by two more acquisitions involving Diagnosys Arad and Eva maternity hospital in Brasov.
MedLife plans to open at least four clinics and boost investments in its hospitals in 2015.
MedLife has been operating on the Romanian market since 1996. It currently has 13 clinics, ten laboratories, six hospitals, 30 GP medical centers, seven PharmaLife Med drugstores and partnerships with 135 medical clinics across the country.
The company is owned by the Marcu family with 51%, SGAM Eastern Europe, owned by a subsidiary of Societe Generale, with 36.25%, and IFC, part of the World Bank Group, with 12.75%.